Task: Answer the multiple-choice question.
Query: Which compound exhibits a 2.871% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: O=C(c1n[nH]c2ccccc12)N1CCN(S(=O)(=O)c2ccc(Cl)cc2)CC1
b: CC(/C=C/c1ccco1)=N\NC(=O)C(O)c1ccccc1
c: C=CCN(c1ccc(OC)cc1)S(=O)(=O)c1ccc(Cl)c(C(=O)OCC(=O)NC2CC2)c1
d: O=S(=O)(c1ccccc1)N1CCN(Cc2cc3c(cc2Br)OCCO3)CC1
e: Cn1c(=O)c2c(n(C)c1=O)=NC1(CCCCC1)ON=2
Answer: d. O=S(=O)(c1ccccc1)N1CCN(Cc2cc3c(cc2Br)OCCO3)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=S(=O)(c1ccccc1)N1CCN(Cc2cc3c(cc2Br)OCCO3)CC1
O=S(=O)(c1ccccc1)N1CCN(Cc2cc3c(cc2Br)OCCO3)CC1
1-(benzenesulfonyl)-4-[(6-bromo-2,3-dihydro-1,4-benzodioxin-7-yl)methyl]piperazine